SCHEMBL6125388

SCHEMBL6125388

Cc1cc(N)c(OCCCS(=O)(=O)O)cc1N=Nc1ccc(N=Nc2ccc(S(=O)(=O)O)cc2)cc1S(=O)(=O)O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ENPP2 Q13822 3/20 0.43
▸ SENP2 Q9HC62 7/20 0.43
▸ SENP1 Q9P0U3 5/20 0.43
▸ SUMO2 P61956 5/20 0.43
▸ SUMO1 P63165 5/20 0.43
▸ SENP7 Q9BQF6 5/20 0.43
▸ SENP3 Q9H4L4 4/20 0.43
▸ RPS6KA3 P51812 1/20 0.39
▸ CD40 P25942 1/20 0.39
▸ CD40LG P29965 1/20 0.39
▸ PHLPP2 Q6ZVD8 4/20 0.39
▸ ATIC P31939 1/20 0.38
▸ BRD4 O60885 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ HTT P42858 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ P2RX5 Q93086 1/20 0.37
▸ P2RX4 Q99571 1/20 0.37
▸ P2RX2 Q9UBL9 1/20 0.37
▸ CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6125389 0.93 ENPP2 (0.42) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL12830667 0.93 ENPP2 (0.42) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL6126049 0.91 P2RX5 (0.41) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL17715468 0.90 ENPP2 (0.44) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL18257343 0.90 P2RX5 (0.43) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL14923380 0.89 SENP2 (0.43) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL12215460 0.89 P2RX5 (0.42) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL16454195 0.87 ENPP2 (0.41) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL14923338 0.87 CTDSP1 (0.41) ENPP2SENP2SENP1SUMO2SUMO1
SCHEMBL14923337 0.87 ENPP2 (0.36) ENPP2SENP2SENP1SUMO2SUMO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3015516-A1 INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL Nippon Kayaku Kabushiki Kaisha (JP) 2016-05-04 — — EP disclosed
EP-2489706-B1 Ink composition and ink jet recording method using the same SEIKO EPSON CORP (JP) 2015-03-04 — — EP disclosed
WO-2015020222-A1 INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL 日本化薬株式会社 (JP) 2015-02-12 — — WO disclosed
EP-2589631-B1 INK COMPOSITION, INKJET RECORDING METHOD AND COLORED BODY NIPPON KAYAKU KK (JP) 2014-08-20 — — EP disclosed
US-8790458-B2 Ink set and droplet ejection apparatus using the ink set SEIKO EPSON CORPORATION (JP) 2014-07-29 — — US disclosed
US-20130288019-A1 INK COMPOSITION, INKJET RECORDING METHOD, AND COLORED MATERIAL NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-10-31 — — US disclosed
US-8496746-B2 Ink composition and ink jet recording method using the same SEIKO EPSON CORPORATION (JP) 2013-07-30 — — US disclosed
EP-2589631-A1 INK COMPOSITION, INKJET RECORDING METHOD AND COLORED BODY Nippon Kayaku Kabushiki Kaisha (JP) 2013-05-08 — — EP disclosed
US-20130002757-A1 INK SET AND DROPLET EJECTION APPARATUS USING THE INK SET SEIKO EPSON CORPORATION (JP) 2013-01-03 — — US disclosed
US-20120213930-A1 INK COMPOSITION AND INK JET RECORDING METHOD USING THE SAME SEIKO EPSON CORPORATION (JP) 2012-08-23 — — US disclosed
EP-2471874-A1 AZO COMPOUNDS, INK COMPOSITIONS, AND COLORED BODIES Nippon Kayaku Kabushiki Kaisha (JP) 2012-07-04 — — EP disclosed
US-8167991-B2 Trisazo compound, ink composition, recording method, and colored article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-05-01 — — US disclosed
US-20090062545-A1 Trisazo Compound, Ink Composition, Recording Method, and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-03-05 — — US disclosed
EP-1975205-A1 TRISAZO COMPOUND, INK COMPOSITION, RECORDING METHOD AND COLORED MATTER Nipponkayaku Kabushikikaisha (JP) 2008-10-01 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062545-A1 Trisazo Compound, Ink Composition, Recording Method, and Colored Article JAK1, TMT1A, CDK1 ENPP2 4384/4885SENP2 4015/4885SENP1 2485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback